Please use this identifier to cite or link to this item:
https://hdl.handle.net/11499/10768
Full metadata record
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Erdoğan, Çağdaş | - |
dc.contributor.author | Ongun, Nedim | - |
dc.contributor.author | Tümkaya, Selim | - |
dc.contributor.author | Alkan, Hakan | - |
dc.contributor.author | Öztürk, Neşe | - |
dc.date.accessioned | 2019-08-16T13:32:52Z | |
dc.date.available | 2019-08-16T13:32:52Z | |
dc.date.issued | 2018 | - |
dc.identifier.issn | 0019-1442 | - |
dc.identifier.uri | https://hdl.handle.net/11499/10768 | - |
dc.identifier.uri | https://doi.org/10.18071/isz.71.0213 | - |
dc.description.abstract | Objectives - Depression and anxiety are frequent in patients with chronic diseases such as diabetic neuropathic pain.The pain seems to be more severe in patients in whom depressive findings accompanied pain symptoms. Pregabalin was reported to have positive effects on anxiety and depression. This brings out the question, whether the pain relief effect of pregabalin is due to its analgesic effect or to its effects on mood? The aim of this study is to find out whether the positive effect of pregabalin in patients with diabetic neuropathic pain is limited to its effect on pain. Thus the question - do patients suffer from less pain or do they less care about pain? -should be answered. Methods - With this aim the NRS scores of 46 patients with diabetic neuropathic pain, whose HADS scores did not change with pregabalin treatment were compared with their baseline levels, retrospectively. Results - The NRS scores of the group were reduced with pregabalin treatment. Conclusion - This results suggests that the reduced pain in pregabalin treatment should be independent from its effects on depression and anxiety. © 2018 Ifjusagi Lap-es Konyvkiado Vallalat. All rights reserved. | en_US |
dc.language.iso | en | en_US |
dc.publisher | Ifjusagi Lap-es Konyvkiado Vallalat | en_US |
dc.relation.ispartof | Ideggyogyaszati Szemle | en_US |
dc.rights | info:eu-repo/semantics/closedAccess | en_US |
dc.subject | Anxiety | en_US |
dc.subject | Depression | en_US |
dc.subject | Diabetic neuropathic pain | en_US |
dc.subject | Pregabalin | en_US |
dc.subject | anticonvulsive agent | en_US |
dc.subject | antidepressant agent | en_US |
dc.subject | pregabalin | en_US |
dc.subject | analgesic agent | en_US |
dc.subject | adult | en_US |
dc.subject | anxiety disorder | en_US |
dc.subject | Article | en_US |
dc.subject | controlled study | en_US |
dc.subject | depression | en_US |
dc.subject | diabetic neuropathy | en_US |
dc.subject | diabetic patient | en_US |
dc.subject | drug dose increase | en_US |
dc.subject | drug efficacy | en_US |
dc.subject | female | en_US |
dc.subject | Hospital Anxiety and Depression Scale | en_US |
dc.subject | human | en_US |
dc.subject | major clinical study | en_US |
dc.subject | male | en_US |
dc.subject | middle aged | en_US |
dc.subject | neuropathic pain | en_US |
dc.subject | non insulin dependent diabetes mellitus | en_US |
dc.subject | numeric rating scale | en_US |
dc.subject | pain assessment | en_US |
dc.subject | patient care | en_US |
dc.subject | retrospective study | en_US |
dc.subject | risk reduction | en_US |
dc.subject | treatment response | en_US |
dc.subject | anxiety | en_US |
dc.subject | drug effect | en_US |
dc.subject | neuralgia | en_US |
dc.subject | nociception | en_US |
dc.subject | pathophysiology | en_US |
dc.subject | psychology | en_US |
dc.subject | treatment outcome | en_US |
dc.subject | Analgesics | en_US |
dc.subject | Diabetic Neuropathies | en_US |
dc.subject | Humans | en_US |
dc.subject | Neuralgia | en_US |
dc.subject | Pain Perception | en_US |
dc.subject | Retrospective Studies | en_US |
dc.subject | Treatment Outcome | en_US |
dc.title | What is the real effect of pregabalin in patients with diabetic neuropathic pain? (do patients suffer from less pain or do they less care about it?) | en_US |
dc.type | Article | en_US |
dc.identifier.volume | 71 | en_US |
dc.identifier.issue | 5-6 | en_US |
dc.identifier.startpage | 213 | |
dc.identifier.startpage | 213 | en_US |
dc.identifier.endpage | 216 | en_US |
dc.authorid | 0000-0002-6231-7834 | - |
dc.authorid | 0000-0001-8461-9131 | - |
dc.identifier.doi | 10.18071/isz.71.0213 | - |
dc.relation.publicationcategory | Makale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı | en_US |
dc.identifier.pmid | 29889464 | en_US |
dc.identifier.scopus | 2-s2.0-85049045415 | en_US |
dc.identifier.wos | WOS:000440959600008 | en_US |
dc.identifier.scopusquality | Q4 | - |
dc.owner | Pamukkale University | - |
item.cerifentitytype | Publications | - |
item.fulltext | No Fulltext | - |
item.grantfulltext | none | - |
item.openairecristype | http://purl.org/coar/resource_type/c_18cf | - |
item.languageiso639-1 | en | - |
item.openairetype | Article | - |
crisitem.author.dept | 14.02. Internal Medicine | - |
crisitem.author.dept | 14.02. Internal Medicine | - |
crisitem.author.dept | 14.02. Internal Medicine | - |
crisitem.author.dept | 14.02. Internal Medicine | - |
Appears in Collections: | PubMed İndeksli Yayınlar Koleksiyonu / PubMed Indexed Publications Collection Scopus İndeksli Yayınlar Koleksiyonu / Scopus Indexed Publications Collection Tıp Fakültesi Koleksiyonu WoS İndeksli Yayınlar Koleksiyonu / WoS Indexed Publications Collection |
CORE Recommender
SCOPUSTM
Citations
1
checked on Dec 7, 2024
WEB OF SCIENCETM
Citations
1
checked on Dec 13, 2024
Page view(s)
44
checked on Aug 24, 2024
Google ScholarTM
Check
Altmetric
Items in GCRIS Repository are protected by copyright, with all rights reserved, unless otherwise indicated.